Health Care · S&P 500
Edwards Lifesciences
A medical device company developing heart valves and critical care monitoring, leading in transcatheter heart valve replacement. S&P 500 constituent. Sector: Health Care (Health Care Equipment). Baseline node ahead of value-chain research; promoted to a full node once AI question demand is observed.
EW Updated Jul 11, 2026 2 AI consumers· 1 recurring
Annual return · 2026-07-10'21+42%'22-42.4%'23+2.2%'24-2.9%'25+15.2%YTD+8.2%
Money in ▸·
Edwards Lifesciences~$5.4B
▸ Money out·
Financials & Segments
- Total revenue · ~$5.4B (FY2024)
- Segments · TAVR · TMTT · Surgical Structural Heart
Revenue from
No refined links yet.
Pays to
No refined links yet.